Genetic changes in precursor blood cells, particularly the BRAFV600E mutation, are linked to higher risks of treatment failure and neurodegeneration in Langerhans cell histiocytosis (LCH).

A nationwide team led by researchers at Baylor College of Medicine, Texas Children’s Hospital and UPMC Children's Hospital of Pittsburgh has proposed a major revision to how Langerhans cell ...

A nationwide team led by researchers at Baylor College of Medicine, Texas Children's Hospital and UPMC Children's Hospital of Pittsburgh has proposed a major revision to how Langerhans cell ...